Karl Clauser

Title: Karl Clauser: Innovator in Immunogenic Compositions

Introduction

Karl Clauser is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of immunology, particularly in the development of immunogenic compositions. His work focuses on addressing critical health challenges, including those posed by viral infections.

Latest Patents

Karl Clauser holds a patent for "Immunogenic compositions and use thereof." This patent describes immunogenic compositions comprising one or more polypeptides that are capable of binding to Major Histocompatibility Complex (MHC) class I. The polypeptides are derived from one or more proteins of SARS-CoV-2. The patent also includes methods for treating and preventing diseases using these immunogenic compositions. He has 1 patent to his name.

Career Highlights

Throughout his career, Karl has worked with prestigious institutions such as the Broad Institute, Inc. and Harvard College. His experience in these organizations has allowed him to collaborate with leading experts in the field of immunology and biotechnology.

Collaborations

Some of his notable coworkers include Pardis Sabeti and Shira Weingarten-Gabbay. Their collaborative efforts have contributed to advancements in understanding and combating infectious diseases.

Conclusion

Karl Clauser's innovative work in immunogenic compositions highlights his commitment to improving public health through scientific research. His contributions are vital in the ongoing fight against viral diseases, particularly in the context of the COVID-19 pandemic.